Suppr超能文献

精神药物的药物不良反应。

Adverse drug reactions of psycopharmacs.

机构信息

Agency for Medicinal Products and Medical Devices, Ksaverska cesta 4, Zagreb, Croatia.

出版信息

Psychiatr Danub. 2010 Sep;22(3):441-5.

Abstract

BACKGROUND

The objective of analysis of ADRs caused by drugs that pertain to the ATC group N (nervous system), as reported to the Croatian Agency for Medicinal Products and Medical Devices for the period from March 2005 to December 2008, was to examine the types of ADRs collected in said period, the profile of reporters and the possible impacts this could have on prescribing this group of medicinal products in the future.

SUBJECTS AND METHODS

A retrospective observational study of ADRs was performed. Drugs causing ADRs were grouped according to the ATC drug classification, and subsequently entered into a database. Data were analyzed in respect of total number, gender, age, type, seriousness, expectedness, outcome, system organ class, suspected drug and reporter.

RESULTS

The findings showed that 15% of all reported ADRs were caused by drugs from the ATC group N. 60% of these were caused by drugs belonging to the ATC subgroups N05 (psycholeptics) and N06A (antidepressants). A significant increase in the percentage of serious ADRs in the examined groups of medicinal products was observed. Analysis of expectedness showed that the share of unexpected ADRs is very high.

CONCLUSION

The distribution of reporters is not satisfactory. The Agency, as regulatory authority, cannot undertake certain measures to improve the safe use of medicinal products without having reports. Only reporting of ADRs can result in changes to benefit all patient populations. Our joint aim should be avoiding a great number of ADRs and maintaining overall safe use of medicinal products.

摘要

背景

分析 2005 年 3 月至 2008 年 12 月期间向克罗地亚药品和医疗器械管理局报告的 ATC 组 N(神经系统)药物引起的不良反应(ADR)的目的是检查该期间收集的 ADR 类型、报告者的特征以及这对未来开处方此类药物可能产生的影响。

方法

进行了 ADR 的回顾性观察研究。根据 ATC 药物分类对引起 ADR 的药物进行分组,然后将其输入数据库。对总数、性别、年龄、类型、严重程度、预期、结果、系统器官类别、可疑药物和报告者进行了数据分析。

结果

研究结果表明,所有报告的 ADR 中有 15%是由 ATC 组 N 的药物引起的。其中 60%是由 ATC 亚组 N05(精神药物)和 N06A(抗抑郁药)的药物引起的。在所检查的药物组中,严重 ADR 的百分比显著增加。对预期性的分析表明,意外 ADR 的比例非常高。

结论

报告者的分布不尽人意。管理局作为监管机构,如果没有报告,就不能采取某些措施来改善药品的安全使用。只有报告 ADR 才能改变所有患者群体的利益。我们的共同目标应该是避免大量的 ADR 并保持药品的整体安全使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验